Announcements Trials
Browse Landscape

Status

Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 147Observational 4Expanded_access 2

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Stomach Neoplasms 4

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 446Surgical Procedures, Operative 164Observation 152Drug Therapy 142Radiotherapy 141Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 78Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 66Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 61Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Ramucirumab × Clear all
NCT06490055 2025-07-18

Predicting the Efficacy in Advanced Gastric Cancer.

City of Hope Medical Center

Completed
162 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06490159 2025-07-11

Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer

City of Hope Medical Center

Recruiting
150 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06666582 2024-10-30

Real-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer

Hellenic Cooperative Oncology Group

Completed
185 enrolled
Gastrointestinal

Stomach Neoplasms

NCT04915807 2021-06-07

Real-world Data (RWD) of Ramucirumab Plus Paclitaxel

Hallym University Medical Center

Unknown
222 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡